SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about transcript of the earnings call

18 Nov 2025 Evaluate
Further to its Letters dated November 9,2025, November 12, 2025 and November 13, 2025, Supriya Lifescience has informed that the Transcript of the Earnings Call held on November 13, 2025 with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025, is available on the Company's website at: https://www.supriyalifescience.com/ir-financial.php.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

649.75 21.75 (3.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×